These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. Bellamy N; Kirwan J; Boers M; Brooks P; Strand V; Tugwell P; Altman R; Brandt K; Dougados M; Lequesne M J Rheumatol; 1997 Apr; 24(4):799-802. PubMed ID: 9101522 [TBL] [Abstract][Full Text] [Related]
4. Challenges of estimating health service utilization for osteoarthritis patients on a population level. Harrold LR; Yood RA; Straus W; Andrade SE; Reed JI; Cernieux J; Lewis BE; Gurwitz JH J Rheumatol; 2002 Sep; 29(9):1931-6. PubMed ID: 12233888 [TBL] [Abstract][Full Text] [Related]
5. Using an evidence-based approach to measure outcomes in clinical practice. MacDermid JC; Grewal R; MacIntyre NJ Hand Clin; 2009 Feb; 25(1):97-111, vii. PubMed ID: 19232920 [TBL] [Abstract][Full Text] [Related]
7. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Ruperto N; Ravelli A; Cuttica R; Espada G; Ozen S; Porras O; Sztajnbok F; Falcini F; Kasapcopur O; Venning H; Bica B; Merino R; Coto C; Ros J; Susic G; Gamir ML; Minden K; See Y; Uziel Y; Mukamel M; Riley P; Zulian F; Olivieri AN; Cimaz R; Girschick H; Rumba I; Cavuto S; Pistorio A; Lovell DJ; Martini A; ; Arthritis Rheum; 2005 Sep; 52(9):2854-64. PubMed ID: 16142708 [TBL] [Abstract][Full Text] [Related]
8. Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. Bellamy N; Carette S; Ford PM; Kean WF; le Riche NG; Lussier A; Wells GA; Campbell J J Rheumatol; 1992 Mar; 19(3):444-50. PubMed ID: 1578461 [TBL] [Abstract][Full Text] [Related]
9. Outcome measurements in scleroderma: results from a delphi exercise. Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843 [TBL] [Abstract][Full Text] [Related]
10. Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning, disability and health as a reference. Schönrich S; Brockow T; Franke T; Dembski R; Resch KL; Cieza A Rehabilitation (Stuttg); 2006 Jun; 45(3):172-80. PubMed ID: 16755436 [TBL] [Abstract][Full Text] [Related]
11. Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials. Maksymowych WP; Landewe R; Boers M; Garnero P; Geusens P; El-Gabalawy H; Heinegard D; Kraus VB; Lohmander S; Matyas J; Saxne T; van der Heijde D J Rheumatol; 2007 Mar; 34(3):634-40. PubMed ID: 17343311 [TBL] [Abstract][Full Text] [Related]
12. Report from the OMERACT Hand Osteoarthritis Special Interest Group: advances and future research priorities. Kloppenburg M; Bøyesen P; Smeets W; Haugen IK; Liu R; Visser W; van der Heijde DM J Rheumatol; 2014 Apr; 41(4):810-8. PubMed ID: 24429165 [TBL] [Abstract][Full Text] [Related]
13. Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the Osteoarthritis Research Society. Hochberg MC; Altman RD; Brandt KD; Moskowitz RW J Rheumatol; 1997 Apr; 24(4):792-4. PubMed ID: 9101520 [TBL] [Abstract][Full Text] [Related]
14. Internal construct validity of the Oxford Knee Scale: evidence from Rasch measurement. Conaghan PG; Emerton M; Tennant A Arthritis Rheum; 2007 Dec; 57(8):1363-7. PubMed ID: 18050174 [TBL] [Abstract][Full Text] [Related]
15. The Short Arthritis Assessment Scale: a brief assessment questionnaire for rapid evaluation of arthritis severity in research and clinical practice. Wolfe F; Michaud K; Kahler K; Omar M J Rheumatol; 2004 Dec; 31(12):2472-9. PubMed ID: 15570654 [TBL] [Abstract][Full Text] [Related]
16. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
17. Clinical assessment in juvenile dermatomyositis. Ravelli A; Ruperto N; Trail L; Felici E; Sala E; Martini A Autoimmunity; 2006 May; 39(3):197-203. PubMed ID: 16769653 [TBL] [Abstract][Full Text] [Related]
18. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]